| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing Direct > 'Short' Copy or 'Long' Copy - Which Works Best? |
|
Main Subject - 'Short' Copy or 'Long' Copy - Which Works Best?
For anyone involved in the development of a marketing message, there has been a long-standing debate for which there is no absolute ans According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product wer. That debate has centered on whether it is better to use sales copy in advertising, direct mail, even brochures or websites, that is ‘ ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in hort’ or ‘long.’ What does that mean? For most of us, we can think of ads we’ve seen in most magazines. They usually feature a pi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. cture or illustration, combined with a headline, combined with a small amount of ‘copy,’ or words that tell us more about the product o here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe service, and ask us to do something. These are ‘short’ copy messages – a couple of paragraphs, maybe even three or four, but not m d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro uch more than that. These marketing messages simply make you aware of a product or service, the ‘brand,’ and probably how to buy it ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc or learn more. These use ‘short’ copy for several reasons. One is simply the amount of space available. But more importantly, a decision was easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi made to use that type of media because the creators of the message were targeting a specific market, and chose to stay with a simple, quick nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to-read message. Often, that decision will come down to whether the company is doing ‘brand’ marketing, or ‘direct’ marketi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ng. Both have their place, but the trend for the last 10-12 years has been for more ‘direct’ marketing. Why? Again, there can be many ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi easons, but near the top of that list will always be that it is more efficient and more accountable. What does THAT mean? ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Direct marketing means that the message goes directly to a target audience who buys directly from the marketer. No stores, no dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod iddleman, no distributors. Starting with the direct mail industry, direct marketing has grown to use other forms of media, to reach the peopl cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e who are a good market for that product/service. The difference is that direct marketing MUST provide enough information for th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen prospect to make a purchase decision… right now. As you can guess, this is where ‘long’ copy comes in. It has proven, in liter t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ally millions of sales letters and direct mail packages, and now websites, to be a very powerful, very efficient way to sell. Does tha ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust mean 'long' copy should always be used? The obvious answer is no. But, if your model includes direct marketing, it is the ONLY y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products way to go. On top of that, direct marketing makes it much easier to know how well the marketing message is working. It either produces . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de results that are profitable, or it doesn’t. Direct marketers KNOW what is working, where ‘brand’ marketers must rely more on sales tren elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ds, usually over a longer period of time. After all that, is the debate over? No… but now you know why there IS a debate tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Axioms and Communication Process Model Six Sigma For Small Businesses Reflections in the Glass Ceiling
|